Lisa Johnson, CEO of BioForward, says the @UWSystem attracts businesses to Wisconsin by generating skilled talent and driving innovation.
“It is critical this innovation is supported and funded by our state...”
#economicdevelopment#innovation#talent
Dear Congress, we support intent of senate bill to lower OOP & ensure all drugs go generic when it’s their time… but not at expense of innovation. Changing 9 to 13 would avert the worst of this bill’s harms.
>1000 signed letter. @SenateHELP https://t.co/AkgA5ryeSo
@AlbertBourla@UofIllinois Congrats! My son finished his first year at @UofIllinois in a dorm room with an intetesting legacy @pmarca Fantastic education paving way towards unlimited future!
Medical Devices are for the Startups ... particularly helpful take on business model innovation for those in the wearable remote monitoring space
https://t.co/f9BHYmJ8G2
@JMRothberg Agree! We need more investment into OTC/point of need rather than central labs and point of care strategies which will remain a bottle neck even with more approved tests
@KatherineJWu Completely agree and trying to understand why this strategy is not being pursued by RADx or BARDA who are focused on central labs and point of care ... democratize testing with over the counter solution
Great opportunity to network with risk capital in Midwest ... VC firm launches virtual matchmaking event for Midwest startups and investors https://t.co/ZNEnF2cqKW via @ChicagoInno
Agree! @avc https://t.co/r2ZpyarsAR Not as many in development as you may think. Tests being funded by BARDA and RADx are to enhance central lab testing and point-of-care testing. Early funding for clever OTC ideas is rate-limiting. See xPRIZE https://t.co/xWWe7rTNuM
A Chicago based team leveraging local resources @mHUBChicago and @StemloopInc assessing aptasensor strategy for OTC option powered with telemetry and companion app for integrated health passport platform will be joining the effort to democratize testing
Calling all diagnostics innovators and tinkerers - https://t.co/pBP4DpiRz5 is offering XPrizes for a range of screens/diagnostics to help bring an end to the Covid-19 pandemic. Please submit your proposal & help save the world. The judges are world-class dx experts.
Our CEO @jrkelly joins @srikosuri, @zhangf, and @JShendure in the MIT Tech Review writing about how we can scale to test millions per day for COVID-19 https://t.co/5pb4epYxxH